PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Glibenclamide reduces secondary brain damage after experimental traumatic brain injury.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24792709 ↗2014Mixed findings

Glibenclamide reduces secondary brain damage after experimental traumatic brain injury.

RatTBIControlled cortical impactSprague-Dawleyn = 14 animals for brain water content and 10 per group for con…Bolus injection followed by continuous delivery via osmotic pumpsBolus 15 min after injury

Model: Parietal craniotomy followed by controlled cortical impact injury

Glibenclamide reduced brain water content (80.47 versus 80.83 percent) and contusion volume at all time points, for example 172.53 versus 299.20 cubic millimetres at 24 h, but did not alter acute physiological parameters or beam-walking performance.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.